The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase 1 study of onalespib, HSP90 inhibitor, and AT7519M, CDK9 inhibitor, in patients with advanced solid tumors.
 
Khanh Tu Do
No Relationships to Disclose
 
Alice P. Chen
No Relationships to Disclose
 
Robert S. Meehan
No Relationships to Disclose
 
Geraldine Helen O'Sullivan Coyne
No Relationships to Disclose
 
Jeffrey G. Supko
No Relationships to Disclose
 
Jane B Trepel
No Relationships to Disclose
 
Jeffrey W. Clark
Research Funding - Pfizer (Inst)
 
John L. Hays
Consulting or Advisory Role - Eisai
 
John F. Lyons
Employment - Astex Pharmaceuticals
Leadership - Astex Pharmaceuticals
Travel, Accommodations, Expenses - Astex Pharmaceuticals
 
Harold N. Keer
Employment - Astex Pharmaceuticals
 
Julia Hewes
No Relationships to Disclose
 
Cameron Sze
No Relationships to Disclose
 
Marissa Marzano
No Relationships to Disclose
 
Ketki Bhushan
No Relationships to Disclose
 
Alona Muzikansky
No Relationships to Disclose
 
S. Percy Ivy
No Relationships to Disclose
 
James H. Doroshow
No Relationships to Disclose
 
Geoffrey Shapiro
Consulting or Advisory Role - G1 Therapeutics; Lilly; Pfizer; Vertex
Research Funding - Aileron Therapeutics (Inst); AstraZeneca (Inst); Bayer (Inst); Cellceutix (Inst); Covidien (Inst); Cyclacel (Inst); Genentech (Inst); GlaxoSmithKline (Inst); Immune Design (Inst); Lilly; Lilly (Inst); Millennium (Inst); Mirati Therapeutics (Inst); Novartis (Inst); Pfizer (Inst); PharmaMar (Inst); PTC Therapeutics (Inst); Puma Biotechnology (Inst); Sanofi (Inst); Tensha Therapeutics (Inst); Vertex (Inst)